This inventor holds 1 USPTO granted patent. Top assignee: Cancer Therapy and Research Center. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: Innovations of Peech S Reddy in Antitumor Agents
Introduction
Peech S Reddy is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. His innovative work focuses on novel bis-naphthalimides that exhibit exceptional properties for cancer treatment.
Latest Patents
Peech S Reddy holds a patent for "Diamine platinum naphthalimide complexes as antitumor agents." This invention provides novel bis-naphthalimides characterized by having a linker containing a heteroatom. The preparation and pharmaceutical compositions of these bis-naphthalimides are detailed, along with various methods of using them. The preferred bis-naphthalimides have a linker of about 8-16 atoms, where the heteroatom can be oxygen, sulfur, sulfur oxide, or sulfur dioxide. These compounds demonstrate exceptional DNA binding properties and show cytotoxicity in both in vitro and in vivo tumor models, particularly against melanoma. Additionally, the patent includes novel mono-naphthalimides linked to a DNA alkylating agent, which have conformational effects on double-stranded DNA and form covalent adducts after extended incubation.
Career Highlights
Peech S Reddy is associated with the Cancer Therapy and Research Center, where he continues to advance his research in cancer therapeutics. His work has the potential to significantly impact the treatment of various cancers, providing new avenues for effective therapies.
Collaborations
Peech has collaborated with notable colleagues, including Mallaiah Mittakanti and Daniel L Dexter. These collaborations enhance the research efforts and contribute to the development of innovative cancer treatments.
Conclusion
Peech S Reddy's contributions to the field of antitumor agents exemplify the importance of innovation in cancer research. His patented inventions pave the way for new therapeutic options that could improve patient outcomes in the fight against cancer.